Cannabis-Derived Drug Reduces PTSD Nightmares in German Study

A cannabis-derived medication significantly reduced nightmares among patients with post-traumatic stress disorder (PTSD), according to German researchers, Forbes Daily reported.

Researchers are studying cannabis-derived compounds as potential treatments for trauma-related nightmares.

The researchers said the medication appeared to specifically reduce nightmares rather than other symptoms associated with PTSD.

More than 33% of patients who received the drug reported that their nightmares disappeared completely. In addition, five out of six patients, or 83.3%, said their overall health had "markedly improved" after treatment.

Prof. Stefan Röpke, one of the researchers, said one of the compounds found in cannabis, tetrahydrocannabinol (THC), reduces dream activity.